NICE announce criteria for access to Daklinza, Harvoni, Viekirax and Exviera

BY IN Medication, Research NO COMMENTS YET , , , ,

The National Institute of Clinical Excellence (NICE) have announced which of the new treatments will be made available by the NHS to people living with hepatitis C. The NICE decisions will widen access to a range of new all-oral, direct acting antiviral treatments beyond those patients with decompensated cirrhosis who were treated from 2014 under